glp 1 vs sglt2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application APhA 2025: GLP-1 Receptor Agonists
Description
[Medicine ACoS
Lowering the dose of GLP-1 receptor agonist or using a slower titration regimen may help to mitigate these effects
remote care enables timely dose adjustments without the need for travel
Hennen, S
For some, it functions as a transitional strategy when tapering from higher doses
[6] [8] Several ongoing clinical trials are specifically examining GLP-1 receptor agonists for alcohol use disorder
